The high-profile vaccine initiative the Coalition for Epidemic Preparedness Innovations (CEPI) has signed its first company agreement, granting Themis an investment of up to $37.5 million to develop new vaccines against Lassa fever and MERS.Original Article
Themis nabs CEPI’s first grant of $37.5M to develop Lassa and MERS vaccines
